Lauxera Capital Partners has held the final closing of its first fund, Lauxera Growth I, at more than EUR260 million (approximately USD300 million), making it one of the leading European funds dedicated to financing innovative HealthTech companies.
Lauxera Capital Partners has held the final closing of its first fund, Lauxera Growth I, at more than EUR260 million (approximately USD300 million), making it one of the leading European funds dedicated to financing innovative HealthTech companies.
Launched in January 2021, Lauxera Growth I exceeded its initial fundraising target of EUR150 million and its initial hard cap of EUR200 million. The fund’s upsized raise reflects the strength and depth of the investment opportunities in fast-growing European HealthTech companies providing innovative solutions.
Lauxera Growth I makes minority Growth and majority Growth Buyout investments leveraging the operational and strategic experience of its team to help founders and managers drive international commercialisation, particularly in the US market. Lauxera Capital invests up to EUR20-40 million in each company and more with the support of its limited partners.
Led by a team of former healthcare executives and experienced investors, Lauxera Growth I achieved a first closing in January 2021 of nearly EUR100 million. The closing was made possible with the strategic support of investors such as Covea, Candriam and Bpifrance, the French national investment bank, which invested in equity and through its Growth fund of fund on behalf of private insurers and the French public financial institution Caisse des Dépôts.
Major European family offices also participated such as Tethys, Compagnie Nationale à Portefeuille (CNP), Financière Dassault, and Italmobiliare. Lauxera Capital Partners’ targeted strategy, the international expertise of its team, and the first investments made by the fund led to additional commitments from other leading investors such as the European Investment Fund (EIF), the Biotech Health Acceleration fund (FABS) handled on behalf of the French government by Bpifrance as part of the Programme d’investissements d’avenir, insurance leaders Matmut and Harmonie Mutuelle (Vyv Group), and Swen Capital Partners.
